Evidence map›Paper›PMID 36278236›Full record

ArticleFrontiers in pharmacology2022

Andre Luis Dias Araujo Mazzari, Mariella Guimarães Lacerda, Flora Aparecida Milton, João Augusto Mulin Montechiari Machado, Simone Batista Pires Sinoti, Anne-Soulene Toullec, Patricia Marquez Rodrigues, Francisco de Assis Rocha Neves, Luiz Alberto Simeoni, Dâmaris Silveira and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Andre Luis Dias Araujo MazzariSchool of Pharmacy, University College London, London, United Kingdom.
Mariella Guimarães LacerdaFaculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil.
Flora Aparecida MiltonFaculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil.
João Augusto Mulin Montechiari MachadoInstituto de Saúde de Nova Friburgo, Universidade Federal Fluminense, Niterói, Brazil.
Simone Batista Pires SinotiFaculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil.
Anne-Soulene ToullecSchool of Pharmacy, University College London, London, United Kingdom.
Patricia Marquez RodriguesFaculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil.
Francisco de Assis Rocha NevesFaculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil.
Luiz Alberto SimeoniFaculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil.
Dâmaris SilveiraFaculdade de Ciências da Saúde, Universidade de Brasília, Brasília, Brazil.
Jose Maria PrietoSchool of Pharmacy, University College London, London, United Kingdom.
Universidade de Brasília · BRUniversity College London · GBLiverpool John Moores University · GBUniversidade Federal Fluminense · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many medicinal plants species from European -such as

Indexed as

Brazildrug metabolismEuropeherbal medicinepharmacokineticspreclinical drug evaluationtoxicology

Identifiers

PMID36278236
PMCPMC9579425
OpenAlexW4301401276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.